Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Scott

Showing results (231-240 of 355) with videos related to

Pageof 36
Sort By:
The Journal of Molecular Diagnostics : JMD|February 13, 2018
Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma ManagementStacy S Hung, Barbara Meissner, Elizabeth A Chavez, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 7, 2017
Evaluation of a SPLUNC1-derived peptide for the treatment of cystic fibrosis lung diseaseShawn T Terryah, Robert C Fellner, Saira Ahmad, et al.
Science Advances|August 1, 2015
The matrikine N-α-PGP couples extracellular matrix fragmentation to endothelial permeabilityCornelia S Hahn, David W Scott, Xin Xu, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B cell fate decisions and yields T cell-depleted lymphomasJie Li, Christopher R Chin, Hsia-Yuan Ying, et al.
Bioinformatics (Oxford, England)|June 11, 2026
LCR-modules: a collection of workflows for cancer genome analysisKostiantyn Dreval, Laura K Hilton, Bruno M Grande, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell LymphomaKit I Tong, Sharon Yoon, Keren Isaev, et al.
British Journal of Haematology|August 16, 2023
ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cellsElaine Y L Chung, Giulio Sartori, Maurilio Ponzoni, et al.
Oncotarget|March 14, 2022
Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patientsEric R Molina, Letitia K Chim, Salah-Eddine Lamhamedi-Cherradi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2020
A Cyclin D1-Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell LymphomaSantiago Demajo, Robert Albero, Guillem Clot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2017
Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin LymphomaFong Chun Chan, Anja Mottok, Alina S Gerrie, et al.
Pageof 36

Showing results (231-240 of 355) with videos related to

Sort By:
Pageof 36
The Journal of Molecular Diagnostics : JMD|February 13, 2018
Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma ManagementStacy S Hung, Barbara Meissner, Elizabeth A Chavez, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 7, 2017
Evaluation of a SPLUNC1-derived peptide for the treatment of cystic fibrosis lung diseaseShawn T Terryah, Robert C Fellner, Saira Ahmad, et al.
Science Advances|August 1, 2015
The matrikine N-α-PGP couples extracellular matrix fragmentation to endothelial permeabilityCornelia S Hahn, David W Scott, Xin Xu, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B cell fate decisions and yields T cell-depleted lymphomasJie Li, Christopher R Chin, Hsia-Yuan Ying, et al.
Bioinformatics (Oxford, England)|June 11, 2026
LCR-modules: a collection of workflows for cancer genome analysisKostiantyn Dreval, Laura K Hilton, Bruno M Grande, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell LymphomaKit I Tong, Sharon Yoon, Keren Isaev, et al.
British Journal of Haematology|August 16, 2023
ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cellsElaine Y L Chung, Giulio Sartori, Maurilio Ponzoni, et al.
Oncotarget|March 14, 2022
Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patientsEric R Molina, Letitia K Chim, Salah-Eddine Lamhamedi-Cherradi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2020
A Cyclin D1-Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell LymphomaSantiago Demajo, Robert Albero, Guillem Clot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2017
Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin LymphomaFong Chun Chan, Anja Mottok, Alina S Gerrie, et al.
Pageof 36